Donor-specific blood transfusion in living-related renal transplantation: fourteen-year experience.
Okazaki
H
H
Department of Surgery, Sendai Shakaihoken Hospital, Japan.
Sato
T
T
Miura
S
S
Amada
N
N
D001379:Azathioprine / Q000627:therapeutic use; D001803:Blood Transfusion; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D019520:Living Donors; D017710:Lymphocyte Transfusion; D012189:Retrospective Studies
D006146:Guanidines; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; C037258:gusperimus